InSilico Medicine Cayman TopCo has reached an AI-driven drug development collaboration with Eli Lilly, totaling over 100 million USD

華爾街見聞
2025.11.10 01:07
由生成式人工智能驅動的生物醫藥科技公司英矽智能近期與全球頭部跨國藥企禮來達成藥物研發戰略合作。雙方將充分發揮英矽智能自主研發的 AI 製藥平台 Pharma.AI 的前沿技術優勢，結合禮來在藥物開發及疾病研究領域的深厚積澱，共同加速創新療法的發現與開發。
Source: 華爾街見聞 The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.